Environmental, social & governance
Our approach to ESG
Bristol Myers Squibb’s commitment to our patients and customers, employees, investors, global communities, suppliers and other stakeholders is an intrinsic part of how we deliver on our mission to provide transformative treatments for patients facing serious diseases.
We believe that driving long-term business value and ESG are linked, and both animate how we live out our purpose as one of the world’s largest pharmaceutical companies. Through our ESG strategy, we seek to mobilize our considerable capabilities and resources to positively impact the communities where we live, work and serve.
Our ESG policies and initiatives reflect our commitment to the uncompromising quality, integrity, inclusion and accountability that are required of our enterprise. As we work to transform patients’ lives through science, we operate with effective governance and the highest ethical standards to deliver on our mission. These values have been core tenets of who we are, what we do, and how we do it since our company was founded in 1858.
2022 ESG Progress & Highlights
of U.S. clinical trial sites located in highly diverse communities, exceeding our goal
product donations in U.S. through the independent BMS Patient Assistance Foundation
of global executives
are women, a 2.9%
YOY increase
people reached through health equity grantsl
of Board Directors comprise women or underrepresented racial and ethnic groups
In 2020 we set bold environmental goals to guide and hold us accountable.
set scientifically validated
goals to reduce our
emissions
100% of purchased
electricity will be procured
from renewable sources
100% zero-emission vehicles in our commercial fleet net-neutral emissions zero waste to landfill equitable water use
2022 partnerships help speed the move toward clean energy
One of Bristol Myers Squibb’s key commitments to environmental responsibility is to purchase 100% of its electricity from renewable sources by 2030. The company took a big stride toward that goal in April 2022, when it executed a 15-year virtual power purchase agreement with EDP Renewables North America LLC for 60 megawatts from the new Cattlemen Solar Park in Milam County, Texas.
Sustainability in 2022 and beyond:
As a leading global biopharmaceutical company, Bristol Myers Squibb develops and delivers high-quality products that help people around the world suffering from serious diseases. That’s a great responsibility — and it’s closely connected to our critical accountability to be good stewards of the global environment. In every aspect of our business, we seek to ensure that our vital work treating patients does not create impacts that damage the health of communities and ecosystems.
2022 partnerships help speed the move toward clean energy
One of Bristol Myers Squibb’s key commitments to environmental responsibility is to purchase 100% of its electricity from renewable sources by 2030. The company took a big stride toward that goal in April 2022, when it executed a 15-year virtual power purchase agreement with EDP Renewables North America LLC for 60 megawatts from the new Cattlemen Solar Park in Milam County, Texas.